Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention

Clinical trial NCT00689377 · COMPLETED

Trial details

NCT number: NCT00689377
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Peripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)

Start date: 2007-05-01
Primary completion: 2008-07-01
Enrollment: 9000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.